SULF1 and neoplasm: Although Sulf1 inhibits angiogenesis and tumorigenesis in vivo (30), a number of clinical studies have found that higher Sulf1 mRNA levels have been associated with tumor tissue compared to normal pancreas in relatively small cohorts of PDAC patients (99, 100).